$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

The objective of this study was to characterize immunoliposomes carrying plasmid DNA with optimal encapsulation efficiency and antibody density. Plasmid DNA was encapsulated by the freezing/thawing method into liposomes composed of POPC (1-palmitoyl-2-oleoyl-sn-glycerol- 3-phosphocholine), DDAB (did...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • site. For this purpose, we prepared pegylated liposomes carrying plasmid DNA, and then investigated the effect of the following various parameters on the DNA amount encapsulated into the liposomes: cationic lipid concentration, initial DNA amount, total lipid amount, DNA size and liposome size. Furthermore, to prepare immunoliposomes capable of both gene delivery and targeting, we conjugated rat IgG to the liposomes carrying plasmid DNA and examined the effect of the ratio of DSPE-PEG 2000-maleimide to rat IgG on the number of IgG molecules conjugated per liposome.
  • For this purpose, we prepared pegylated liposomes carrying plasmid DNA, and then investigated the effect of the following various parameters on the DNA amount encapsulated into the liposomes: cationic lipid concentration, initial DNA amount, total lipid amount, DNA size and liposome size. Furthermore, to prepare immunoliposomes capable of both gene delivery and targeting, we conjugated rat IgG to the liposomes carrying plasmid DNA and examined the effect of the ratio of DSPE-PEG 2000-maleimide to rat IgG on the number of IgG molecules conjugated per liposome.
  • In this study, we prepared and characterized immunoliposomes which can be more stable in the blood stream by polyethyleneglycol (PEG)-derivatized lipids and target the effect site by conjugating IgG (monoclonal antibody) to the tips of the PEG strands. In Sepharose CL-4B column chromatography, the co-location of the two peaks (Fig.
  • To determine if the number of IgG molecules conjugated per liposome was affected by the ratio of DSPE-PEG 2000-maleimide to IgG, a series of studies were performed with variations in the ratio of 5 to 1, 10 to 1 and 20 to 1 (Fig. 5). For the ratios of 10 to 1 and 20 to 1, 0.

대상 데이터

  • concentration. DDAB content used in this study was 1, 3, 4, 5, and 7 mole% (0.2, 0.6, 0.8, 1.0, and 1.4 μmole). To maintain the total lipid amount as 20 μmole, neutral lipid (POPC) concentration was decreased according to increasing DDAB concentration.
  • I). Lipid composition was kept at 92 mole% POPC, 4 mole% DDAB, 3 mole% DSPE-PEG 2000 and 1 mole% DSPE-PEG 2000-maleimide, and 100 μg of plasmid DNA (pGl_2 clone 753) was used. To control liposome size, the liposomes carrying plasmid DNA were forced through 2 stacked polycarbonate filters with pore size of 400 nm, 200 nm or 100 nm.
  • Pardridge (University of California, Los Angeles, USA). Rat IgG was purchased from Sigma-Aldrich (St. Louis, MO, USA).
  • Effect of initial DNA and total lipid amount on DNA amount encapsulated into the liposomes. The liposomes were composed of 92 mole% POPC, 4 mole% DDAB, 3 mole% DSPE-PEG 2000 and 1 mole% DSPE-PEG 2000-maleimide. (A) Effect of the initial DNA amount on the DNA amount encapsulated into the liposomes.
  • 4). The plasmids used in this study were pGL2 clone 753 (5.8 kb), pSV clone 756 (6.8 kb) and pCEP4 clone 790 (10.6 kb). The DNA amount encapsulated into the liposomes was reduced with increasing plasmid DNA size.
본문요약 정보가 도움이 되었나요?

참고문헌 (24)

  1. Bailey, A. L. and Sullivan, S. M., Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta, 1468, 239-252 (2000) 

  2. Boris-Lawrie, K. A. and Temin, H. M., Recent advances in retrovirus vectortechnology. Curr. Opin. Genet. Dev., 3, 102-109 (1993) 

  3. Harrison, G. S.,Wang, Y., Tomezak, J., Hogan, C., Shpall, E. J., Curiel, T. J., and Feigner, P. L., Optimization of genetransfer using cationic lipids in cell lines and primary human CD4+ and CD34 hematopoietic cells. Biotechniques, 19, 816-823 (1995) 

  4. Huwyler, J., Dafang, W., and Pardridge, W. M., Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. U.S.A., 93,14164-14169 (1996) 

  5. Lamb, B. T., Sisodia, S. S., Lawler, A. M., Siunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., and Gearhart, J. D., Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet., 5, 22-30 (1993) 

  6. Li, S. and Huang, L., In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 4, 891-900 (1997) 

  7. Li, S. and Huang, L., Nonviral gene therapy: promises and challenges. GeneTher., 7, 31-34 (2000) 

  8. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W., Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediated specific and efficient drug delivery to EGFR- and EGFRvllloverexpressing tumor cells. Cancer Res., 63, 3154-3161 (2003) 

  9. Maruyama, K., Ishida, O., Takizawa, T., and Moribe, K., Possibility of active targeting to tumor tissues with liposomes. Adv. Drug Deliv. Rev., 40, 89-102 (1999) 

  10. Miller, A. D., Retroviral vectors. Curr. Top. Microbiol. Immunol., 158, 1-24 (1992) 

  11. Monnard, P.-A., Oberholzer,T., and Luisi, P. L., Entrapment of nucleic acids in liposomes. Biochim. Biophys. Acta,1329, 3950 (1997) 

  12. Nabel, G. J., Nabel, E. G., Yang, Z.-Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. E., Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A., 90, 11307-11311 (1993) 

  13. Pardridge, W. M., Buciak, J. L., and Yoshikawa, T., Transport of recombinant CD4 through the rat blood-brain barrier in vivo. J. Pharmacol. Exp. Ther., 261, 1175-1180 (1992) 

  14. Park, H. M., Chung, S. Y., Go, E. J., and Lee, H. J., Preparation and characterization of plasmid DNA encapsulated in liposomes. J. Kor. Pharm. Sci., 33, 209-213 (2003) 

  15. Pastorino, F., Stuart, D., Ponzoni, M., and Allen, T. M., Targeted delivery of antisense oligonucleotides in cancer. J. Control Release, 74, 69-75 (2001) 

  16. Saravolac, E. G., Ludkovski,O., Skirrow, R., Ossanlou, M., Zhang, Y. P., Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, P. R., and Scherrer, P., Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J. Drug Target, 7, 423-437 (2000) 

  17. Schatzlein, A. G., Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs, 12, 275-304 (2001) 

  18. Setoguchi, Y., Jaffe, H. A., Chu, C.-S., and Crystal, R. G., Intraperitoneal in vivo gene therapy to deliver alpha 1antitrypsin to the systemic circulation. Am. J. Resp. Cell. Mol. BioI., 10, 369-377 (1994) 

  19. Shi, N. and Pardridge, W. M., Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A., 97, 7567-7572 (2000) 

  20. Smith, T. A., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., and Kaleko, M., Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet., 5, 397-402 (1993) 

  21. Stuart, D. D. and Allen, T. M., A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta,1463, 219-229 (2000) 

  22. Worgall, S., Wolff, G., Falck-Pedersen, E., and Crystal, R. G., Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther., 8, 37-44 (1997) 

  23. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M., Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69, 2004-2015 (1995a) 

  24. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M., Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U. S. A., 91, 4470-4411 (1995b) 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로